CAMP4 Therapeutics Corporation Share Price

CAMP4 Therapeutics Corporation Share Price

NASDAQ: CAMP | Micro Cap
$4.01
+$0.13 (3.35%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CAMP4 Therapeutics Corporation Stock Performance

Open
$3.93
Prev. Close
$3.88
Circuit Range
N/A
Day Range
$3.93 - $4.03
Year Range
$2.92 - $7.67
Volume
5,826
Average Traded
$3.99

CAMP4 Therapeutics Corporation Share Price Today

As of 18 November 2026, CAMP4 Therapeutics Corporation's share price is $4.01. The stock opened at $3.93, compared to its previous close of $3.88. During today's trading session, CAMP4 Therapeutics Corporation's share price traded between $3.93 and $4.03, with an average price of $3.98. Over the past 52 weeks, the stock has recorded a high of $7.67 and a low of $2.92. In terms of performance, CAMP4 Therapeutics Corporation's share price has declined by 8.66% over the last six months and is up 4.16% on a year-on-year basis.

CAMP4 Therapeutics Corporation Share Price Chart

Line chart of the CAMP4 Therapeutics Corporation price trend over the selected period. The price rose overall, ranging from 3.90 to 4.09, ending at 4.01.
$3.93$4.03
L
Show Current Price
H

CAMP4 Therapeutics Corporation Stock Fundamentals & Key Indicators

Market Cap
$121.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.93
Revenue (TTM)
$3.50B
Return On Equity (TTM)
-113.08%
Profit Margin
-2297.14%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
28.10%

CAMP4 Therapeutics Corporation Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.35$1.29$1.78$1.90
Net Profit-$40.28-$18.33-$33.53-$28.96
Net Profit Margin-11508.57%-1420.93%-1883.71%-1524.21%
Income ChangeN/A54.49%-82.92%13.63%

CAMP4 Therapeutics Corporation Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.65$3.50
Net Profit-$51.79-$80.40
Net Profit Margin-7967.69%-2297.14%
Income ChangeN/A-55.24%

About CAMP4 Therapeutics Corporation

Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.

CAMP4 Therapeutics Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$4.04
$4.01
+0.25%
Oct 2026
$4.00
$4.00
-0.74%
Sep 2026
$3.85
$4.03
-2.89%
Aug 2026
$3.66
$4.15
+20.29%
Jul 2026
$4.46
$3.45
-21.23%
Jun 2026
$4.62
$4.38
-0.23%
May 2026
$4.26
$4.39
+5.40%
Apr 2026
$4.37
$4.17
-6.40%
Mar 2026
$4.15
$4.45
+1.02%
Feb 2026
$3.73
$4.41
+17.47%
Jan 2026
$6.12
$3.75
-38.97%
Dec 2025
$3.27
$6.14
+59.61%

CAMP Share Price FAQs